Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04914741
Title A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL) (COALITION)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia

diffuse large B-cell lymphoma

B-cell lymphoma


Cyclophosphamide + Doxorubicin + Prednisolone + Rituximab + RO7082859 + Vincristine Sulfate

Cyclophosphamide + Doxorubicin + Polatuzumab vedotin-piiq + Prednisolone + Rituximab + RO7082859

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Concord Repatriation General Hospital Recruiting Camperdown New South Wales 2050 Australia Details
St Vincent's Public Hospital Sydney Recruiting Darlinghurst New South Wales 2010 Australia Details
Calvary Mater Newcastle Recruiting Newcastle New South Wales 2298 Australia Details
Prince of Wales Hospital Recruiting Randwick New South Wales 2031 Australia Details
Royal Brisbane and Women's Hospital Recruiting Herston Queensland 4029 Australia Details
Royal Adelaide Hospital Recruiting Adelaide South Australia 5000 Australia Details
Barwon Health Recruiting Geelong Victoria 3220 Australia Details
Cabrini Hospital Recruiting Malvern Victoria 3144 Australia Details
Peter MacCallum Cancer Centre Recruiting Melbourne Victoria 3000 Australia Details
St Vincent's Hospital Melbourne Recruiting Melbourne Victoria 3065 Australia Details
Alfred Hospital Recruiting Melbourne Victoria Australia Details
Epworth Healthcare Recruiting Melbourne Victoria Australia Details
Sir Charles Gairdner Hospital Recruiting Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from for the field